Discover 1,134 paid clinical trials in Bridgeport, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,134
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
for
LGLL - Large Granular Lymphocytic Leukemia,
Location: New Haven CT, New York NY, Boston MA, Fairfax VA,
Sponsor: Dren Bio
Sex: All
Age: 18+
Code: NCT05475925
Phase 1, Phase 2, Recruiting
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans
A Single Site Prospective, Non-randomized Study of Partial Breast Intracavitary Brachytherapy Devices to Evaluate Local Tumor Control, Cosmetic Outcome and Toxicities.
for
This Study Has Been Designed to Compile Information on the Efficacy of the Partial Breast Intracavitary Brachytherapy in the Post Market Setting.,
Location: Bridgeport CT
Sponsor: St. Vincent's Medical Center
Sex: Female
Age: 45+
Code: NCT01813825
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: New Haven CT, New York NY, Fairfax VA, Durham NC,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07196644
Phase 2, Recruiting
Featured
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia
Location: New Haven CT, New York NY, Providence RI, Worcester MA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06428019
Phase 3, Recruiting
Featured
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
for
Acne Scars
Location: Westport CT, Mount Kisco NY, Baltimore MD, Arlington VA,
Sponsor: AbbVie
Sex: All
Age: 22+
Code: NCT07207369
Phase 3, Recruiting
FeaturedActive & Responsive
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder (GAD)
Location: Cromwell CT, Brooklyn NY, Springfield MA, Princeton NJ,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06846320
Phase 2, Recruiting
A Clinical Trial Comparing 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP to a Control Group Post-SRP.
for
Periodontitis (Stage 3)
Location: New London CT, Boston MA, Richmond VA, La Vista NE,
Sponsor: McGuire Institute
Sex: All
Age: 30 - 70+
Code: NCT06914596
Recruiting
Integrated Cancer Repository for Cancer Research
for
Pancreatic Cancer, Thyroid Cancer, Lung Cancer,
Location: Manchester CT, Holyoke MA, Glens Falls NY, Utica NY,
Sponsor: University of Nebraska
Sex: All
Age: 19 - 70+
Code: NCT02012699
Recruiting
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
Location: Waterford CT, Hagerstown MD, West Columbia SC,
Sponsor: Ocular Therapeutix, Inc.
Sex: All
Age: 50+
Code: NCT07516132
Phase 3, Recruiting
Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
for
Age-related Wet Macular Degeneration
Location: Manchester CT, Philadelphia PA, Erie PA, Carmel IN,
Sponsor: Caregen Co. Ltd.
Sex: All
Age: 50+
Code: NCT06132035
Phase 1, Recruiting
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
for
Radiation Retinopathy, Visual Impairment
Location: Manchester CT, Philadelphia PA, Boston MA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18+
Code: NCT05844982
Phase 3, Recruiting
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
for
HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
Location: New York NY, Sarasota FL, Houston TX, New Haven CT,
Sponsor: Avenzo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06998407
Phase 1, Phase 2, Recruiting
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Location: New York NY, Boston MA, Houston TX, Austin TX,
Sponsor: Avenzo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07193511
Phase 1, Phase 2, Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma